Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record SystemsLaura J. Rasmussen‐Torvik, Steven E. Scherer, R. Li et al.|Clinical Pharmacology & Therapeutics|2014Cited by 246
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkWilliam S. Bush, DM Roden, DR Crosslin et al.|Clinical Pharmacology & Therapeutics|2016Cited by 189
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and ProjectsSimona Volpi, Mary V. Relling, Carol J. Bult et al.|Clinical Pharmacology & Therapeutics|2018Cited by 131
Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathwaySimona Volpi, Greti Aguilera|Journal of Molecular Endocrinology|2006Cited by 15
CYP2D6-Guided Opioid Management and Postoperative Pain ControlLarisa H. Cavallari, Ruth C. Lehan, Rachel A. Myers et al.|JAMA Network Open|2026Cited by 4